ATRA vs J · rev $128.9M vs P/E 36, $14.40B cap
Atara Biotherapeutics Inc (ATRA) versus Jacobs Solutions Inc. (J) — a side-by-side from cached financials, not a winner call.
Atara Biotherapeutics Inc (ATRA) is a biotechnology company listed on NASDAQ.
Jacobs Solutions Inc. (J) is a engineering & construction company listed on US.
Latest reported ATRA revenue for 2024-12-31 was $128.9M. Net income was -$85.4M. Revenue was up 1404.0% from 2023-12-31 to 2024-12-31. ATRA currently screens at market cap $87.1M.
J does not have a complete income-statement cache yet.
ATRA currently screens at market cap $87.1M. J currently screens at market cap $14.40B and trailing P/E 36.0.
Not investment advice. Open the ATRA and J stock pages for the full models.
Not investment advice.